Movers of most recent trading session: Comcast Corporation (CMCSA), Edge Therapeutics, Inc. (EDGE)


Comcast Corporation (CMCSA)

Comcast Corporation is a global media and technology company with two primary businesses, Comcast Cable and NBCUniversal. Comcast Cable is one of the nation’s largest video, high-speed internet, and phone providers to residential customers under the XFINITY brand, and also provides these services to businesses. It also provides wireless and security and automation services to residential customers under the XFINITY brand. NBCUniversal operates news, entertainment and sports cable networks, the NBC and Telemundo broadcast networks, television production operations, television station groups, Universal Pictures and Universal Parks and Resorts.

Comcast Corporation (CMCSA)‘s Financial Overview

Comcast Corporation (CMCSA) surged 0.88% yesterday to close its trading session at $33.28. The company has 1 year Price Target of $48.13. Comcast Corporation has 52-Week high of $44 and 52-Week Low of $32.74. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 32.12 Million shares yesterday. The firm shows the market capitalization of $154.85 Billion.

Comcast Corporation (CMCSA) reported its last quarterly earnings on 12/30/2017 where the firm reported its Actual EPS of $0.49/share against the analyst consensus estimate of $0.47/share. The difference between the actual and expected EPS is $0.02 a share with a surprise factor of 4.3%.

The firm is trading with SMA20 of -6.48 Percent, SMA50 of SMA50 Percent and SMA200 of -14.15 percent. Comcast Corporation has P/S value of 1.83 while its P/B value stands at 2.26. Similarly, the company has Return on Assets of 12.3 percent, Return on Equity of 38.8 percent and Return on Investment of 9.7 Percent. The company shows Gross Margin and Operating Margin of 70 percent and 21.2 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 1.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 29 analysts offering 12-month price forecasts for Comcast Corp have a median target of 49.00, with a high estimate of 56.00 and a low estimate of 42.00. The median estimate represents a +47.24% increase from the last price of 33.28.

Edge Therapeutics, Inc. (EDGE)

Edge Therapeutics, Inc. is a biotechnology company which discovers, develops and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product candidate which are in preclinical trial EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage, EG-1964, to prevent recurrent bleeding after treatment for cSDH and EG-1963, to prevent rebleeding following surgeries outside the brain. Edge Therapeutics, Inc. is headquartered in Berkeley Heights, New Jersey.

Edge Therapeutics, Inc. (EDGE)’s Financial Outlook

The 3 analysts offering 12-month price forecasts for Edge Therapeutics Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 17.00. The median estimate represents a +1,197.71% increase from the last price of 1.31.

The Stock declined-91.6% and closed its last trading session at $1.31. The company has the market capitalization of $41.29 Million. The stock has 52-week high of $17.77 and 52-Week low of $1.15. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 31.46 Million shares. The company has a total of 31.52 Million shares outstanding.

Edge Therapeutics, Inc. (EDGE) in the last quarter reported its actual EPS of $-0.45/share where the analyst estimated EPS was $-0.43/share. The difference between the actual and Estimated EPS is $-0.02. This shows a surprise factor of -4.7 percent.

The company has YTD performance of -86.02 percent. Beta for Edge Therapeutics, Inc. stands at 0 while its ATR (average true range) is 1.92. The company has Weekly Volatility of 19.98%% and Monthly Volatility of 9.41%.

Edge Therapeutics, Inc. has distance from 20-day Simple Moving Average (SMA20) of -91.95%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of -88.38%.